Murchinson Ltd. 13D and 13G filings for Immix Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-03-02 2:57 pm Sale |
2022-02-25 | 13G | Immix Biopharma, Inc. IMMX |
Murchinson Ltd. | 0 0.000% |
-695,600 (Position Closed) |
Filing |
| 2022-02-09 5:12 pm Purchase |
2021-12-31 | 13G | Immix Biopharma, Inc. IMMX |
Murchinson Ltd. | 695,600 5.280% |
695,600 (New Position) |
Filing |